Myelodysplastic syndromes: open trials in South Korea

10 open trials have a site in South Korea. Registry data; only the trial team decides who can take part.

NCT06499285
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Trial Treatment · Phase 3 · Takeda
Kyungpook National University Hospital, Daegu · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Samsung Medical Center, Seoul · Asan Medical Center, Seoul · Seoul National University Hospital, Seoul · Soon Chun Hyang University Hospital Seoul, Seoul
Registry updated 2026-11-06
NCT07422480
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions
Trial Treatment · Phase 3 · Takeda
Seoul National University Bundang Hospital, Seongnam-si · Korea University Anam Hospital, Seoul · Seoul National University Hospital, Seoul · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Soon Chun Hyang University Hospital Seoul, Seoul · Samsung Medical Center, Seoul
Registry updated 2026-11-06
NCT06788509
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Severance Hospital, Yonsei University Health System, Seoul
Registry updated 2026-11-04
NCT07155226
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Trial Treatment · Phase 1/2 · AstraZeneca
Seoul
Registry updated 2026-10-23
NCT07355478
Asia Myelodysplastic Syndrome (MDS) Registry
Research · Bristol-Myers Squibb
Seoul
Registry updated 2026-10-08
NCT04771130
A Study of BGB-11417 in Participants With Myeloid Malignancies
Trial Treatment · Phase 1/2 · BeOne Medicines
Samsung Medical Center, GangnamGu · Severance Hospital Yonsei University Health System, SeodaemunGu
Registry updated 2026-09-14
NCT06847867
A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
Trial Treatment · Phase 2 · GlaxoSmithKline
Seongnam-si Gyeonggi-do · Seoul
Registry updated 2026-06-02
NCT04988555
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Trial Treatment · Phase 1/2 · Sumitomo Pharma America, Inc.
Chonnam National University Hwasun Hospital, Hwasun · Seoul National University Hospital, Seoul · Samsung Medical Center, Seoul · The Catholic University of Korea, Seoul
Registry updated 2026-03-24
NCT03850574
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Trial Treatment · Phase 1/2 · Aptose Biosciences Inc.
Kyungpook National University Hospital, Daegu · Pusan National University Hospital, Pusan · Seoul National University Bundang Hospital, Seongnam · Seoul National University Hospital, Seoul · Samsung Medical Center, Seoul · Asan Medical Center, Seoul
Registry updated 2025-08-26
NCT06073860
A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia
Research · Bristol-Myers Squibb
Seoul · Novotech Laboratory Korea Co., Ltd., Seoul
Registry updated 2024-11-06

All Myelodysplastic syndromes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error